You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Potassium Chloride 10meq In Plastic Container patents expire, and when can generic versions of Potassium Chloride 10meq In Plastic Container launch?

Potassium Chloride 10meq In Plastic Container is a drug marketed by Baxter Hlthcare and Icu Medical Inc and is included in two NDAs.

The generic ingredient in POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-seven suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Potassium Chloride 10meq In Plastic Container

A generic version of POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER?
  • What are the global sales for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER?
Summary for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
Drug patent expirations by year for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
Pharmacology for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER

US Patents and Regulatory Information for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904-001 Dec 26, 1989 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Icu Medical Inc POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161-001 Nov 30, 1992 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904-005 Dec 17, 1990 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Icu Medical Inc POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161-005 Nov 30, 1992 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Potassium Chloride

Introduction

Potassium chloride, a versatile compound, is integral to various industries, including pharmaceuticals, agriculture, and industrial applications. This article explores the current market dynamics, growth drivers, challenges, and the financial trajectory of potassium chloride, with a specific focus on its pharmaceutical grade, particularly the 10mEq formulation in plastic containers.

Global Market Overview

The global potassium chloride market is diverse and expansive, with applications spanning multiple sectors. Here are some key aspects of the market:

  • Market Size and Growth: The global potassium chloride market was valued at $12.56 billion in 2021 and is forecasted to reach $19.44 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 5.98% from 2023 to 2030[1].
  • Pharma Grade Segment: The pharma-grade potassium chloride market, specifically, is estimated to be worth $15 million in 2024 and is projected to grow to $22 million by 2032, with a CAGR of 6.5% during the review period[2].

Market Drivers

Several factors are driving the growth of the potassium chloride market:

Increasing Adoption in Fertilizers

Potassium chloride is crucial in the agricultural sector as a fertilizer. Potassium is the third main crop nutrient after nitrogen and phosphorus, and its use in fertilizers is a major driving factor for the market. According to the International Potash Institute, potassium and chloride ions are essential for plant growth and development[1].

Pharmaceutical Applications

In the healthcare sector, potassium chloride is used to manage and treat hypokalemia, a condition characterized by low potassium levels in the blood. The demand from pharmaceutical applications is a significant growth driver for the market[1].

Industrial Demand

The oil & gas and food industries also contribute to the demand for potassium chloride. Its use in these sectors is expected to drive the market growth over the estimated period[1].

Market Constraints and Challenges

Despite the growth drivers, the market faces several challenges:

Economic Impact of COVID-19

The COVID-19 pandemic had a significant impact on the global potassium chloride market, leading to a readjustment in market size and growth projections. However, the market is expected to recover and grow steadily in the post-pandemic period[2].

Price Volatility

Fluctuating prices of potassium chloride can affect production costs and profitability for manufacturers, posing a significant challenge to the market[2].

Health Issues from Chemical Fertilizers

The use of chemical fertilizers, including potassium chloride, can lead to health issues and environmental concerns, which may hinder market growth[1].

Regional Analysis

The global potassium chloride market is segmented across various regions, each with its own dynamics:

Asia Pacific

The Asia Pacific region, particularly countries like India and China, is a significant contributor to the market. India has 60.2% of its land under the agriculture sector, and China has 56.1% of its land dedicated to agriculture, making these countries major consumers of potassium chloride[1].

North America

North America, with its increasing demand for potassium chloride in the agriculture and healthcare sectors, is also a key region in the market[1].

Europe

Europe is another significant region, especially for the pharma-grade segment, accounting for about 30% of the global market[2].

Key Players and Competitive Landscape

The market is dominated by several major players:

Major Players

Companies like ICL (ICL-IP), K+S, and Morton have a significant presence in the global market. These companies are involved in various strategic initiatives to maintain their market share and competitiveness[2].

Competitive Strategies

Key players are focusing on cost optimization, efficiency improvements, and strategic initiatives such as production facility expansions, acquisitions, and joint ventures. For example, K+S generated significant synergies in procurement, logistics, production, and sales and marketing, and reduced the average cost of potash production[2].

Financial Performance and Outlook

Revenue Projections

The broader potassium chloride market is projected to reach $19.44 billion by 2029, while the pharma-grade segment is forecasted to reach $22 million by 2032. The market is expected to grow steadily, driven by increasing demand in various sectors[1][2].

Cost Optimization

Companies are focusing on cost optimization to enhance profitability. For instance, K+S reduced its average cost of potash production to less than €200 per tonne through various synergies and efficiency improvements[2].

Pharmaceutical Grade Potassium Chloride: 10mEq in Plastic Containers

Market Size and Growth

The pharma-grade potassium chloride market, including the 10mEq formulation in plastic containers, is part of the broader pharma-grade segment. This segment is expected to grow at a CAGR of 6.5% from 2024 to 2032, reaching $22 million by 2032[2].

Applications

Potassium chloride 10mEq in plastic containers is primarily used to treat hypokalemia. The dosage typically ranges from 16 to 100 milliequivalents (mEq) per day, divided into two or three smaller doses[5].

Key Players in Pharma Grade Segment

Companies such as Upsher-Smith, Aurobindo Pharma, Macleods, Viatris, and Yichang Humanwell Pharmaceutical are major players in the pharma-grade potassium chloride market, including the extended-release tablets segment[4].

Extended-Release Tablets Market

Market Size and Growth

The Potassium Chloride Extended-Release Tablets Market was valued at $214 million in 2023 and is projected to reach $266 million by 2030, growing at a CAGR of 3.1% during the forecast period[4].

Key Applications

These tablets are used in hospitals, clinics, and other healthcare settings to manage hypokalemia. The main types include 8mEq and 10mEq formulations[4].

Conclusion

The potassium chloride market, including the pharma-grade segment and specifically the 10mEq formulation in plastic containers, is poised for steady growth driven by increasing demand in fertilizers, pharmaceutical applications, and industrial expansion. Despite challenges such as price volatility and competition, key players are implementing strategic initiatives to maintain market share and drive growth.

Key Takeaways

  • Global Market Growth: The global potassium chloride market is expected to reach $19.44 billion by 2029.
  • Pharma Grade Growth: The pharma-grade potassium chloride market is forecasted to grow at a CAGR of 6.5% from 2024 to 2032.
  • Regional Significance: Asia Pacific, North America, and Europe are significant contributors to the global market.
  • Key Applications: Fertilizers, pharmaceuticals, and industrial sectors are the primary applications.
  • Major Players: ICL, K+S, Morton, Upsher-Smith, Aurobindo Pharma, and others are key players in the market.

FAQs

Q: What is the projected market size of the global pharma-grade potassium chloride market by 2032?

A: The global pharma-grade potassium chloride market is forecasted to reach $22 million by 2032[2].

Q: Which region is the largest production area for pharma-grade potassium chloride?

A: Europe is the largest production area for pharma-grade potassium chloride, accounting for about 30% of the global market[2].

Q: What are the primary drivers of the global potassium chloride market?

A: The primary drivers include increasing adoption in fertilizers, demand from pharmaceutical and medical applications, and industrial expansion[1][3].

Q: How has the COVID-19 pandemic affected the potassium chloride market?

A: The pandemic led to a readjustment in market size and growth projections, but the market is expected to recover and grow steadily in the post-pandemic period[2].

Q: What is the typical dosage for potassium chloride 10mEq in plastic containers?

A: The typical dosage ranges from 16 to 100 milliequivalents (mEq) per day, divided into two or three smaller doses[5].

Sources

  1. Cognitive Market Research: Global Potassium Chloride Market Report 2024.
  2. DrugPatentWatch: Potassium Chloride - Generic Drug Details.
  3. Market Research Future: Potassium Chloride Market Size, Share & Trends 2032.
  4. Valuates Reports: Potassium Chloride Extended-Release Tablets Market.
  5. Mayo Clinic: Potassium supplement (oral route, parenteral route).

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.